Drugs / hexaminoavolunate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02660190 | Feb 2016 → Dec 2017 | urinary bladder cancer | Jørgen Bjerggaard Jensen | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hexaminoavolunate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02660190 ↗ |